- Home
- LCTX vs FTLF Comparison
LCTX vs FTLF Comparison
Compare LCTX & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- FTLF
- Stock Information
- Founded
- LCTX 1990
- FTLF 2005
- Country
- LCTX United States
- FTLF United States
- Employees
- LCTX N/A
- FTLF N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- FTLF Medicinal Chemicals and Botanical Products
- Sector
- LCTX Health Care
- FTLF Health Care
- Exchange
- LCTX Nasdaq
- FTLF Nasdaq
- Market Cap
- LCTX 127.7M
- FTLF 150.4M
- IPO Year
- LCTX N/A
- FTLF N/A
- Fundamental
- Price
- LCTX $0.62
- FTLF $32.48
- Analyst Decision
- LCTX Strong Buy
- FTLF Strong Buy
- Analyst Count
- LCTX 5
- FTLF 1
- Target Price
- LCTX $4.80
- FTLF $40.00
- AVG Volume (30 Days)
- LCTX 2.4M
- FTLF 9.1K
- Earning Date
- LCTX 03-06-2025
- FTLF 02-20-2025
- Dividend Yield
- LCTX N/A
- FTLF N/A
- EPS Growth
- LCTX N/A
- FTLF 93.67
- EPS
- LCTX N/A
- FTLF 1.70
- Revenue
- LCTX $8,719,000.00
- FTLF $62,755,000.00
- Revenue This Year
- LCTX N/A
- FTLF $25.54
- Revenue Next Year
- LCTX $41.15
- FTLF $7.30
- P/E Ratio
- LCTX N/A
- FTLF $19.13
- Revenue Growth
- LCTX N/A
- FTLF 40.17
- 52 Week Low
- LCTX $0.48
- FTLF $20.87
- 52 Week High
- LCTX $1.61
- FTLF $35.49
- Technical
- Relative Strength Index (RSI)
- LCTX 56.03
- FTLF 54.23
- Support Level
- LCTX $0.55
- FTLF $29.40
- Resistance Level
- LCTX $0.60
- FTLF $33.13
- Average True Range (ATR)
- LCTX 0.04
- FTLF 0.89
- MACD
- LCTX 0.01
- FTLF 0.20
- Stochastic Oscillator
- LCTX 100.00
- FTLF 77.00
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, and sports drink products, meal replacement products and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products and Supplements.